Hll Biotech Limited, a active private limited union government company, was established on 12 March 2012 in Thiruvananthapuram, Kerala, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290KL2012GOI030732. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹285.00 Cr and a paid-up capital of ₹27.49 Cr.
It upholds a compliant status. Employing 99 professional, Its leadership includes Amitabh Soni (Director), Hoveyda Abbas (Nominee Director), Vijay Nehra (Nominee Director). Past directors included Dharitri Panda, Amitabh Soni, Sanjay Kumar. It holds ₹459.00 Cr open charges and no settled loans. Its latest AGM occurred on 11 December 2024, with the balance sheet filed on 31 March 2024. It is based at Kumari Geetha S, Neena Mg , Geena Jayaprakash (Joint Owners), Aswathi, Neens, Ward No.42 Door No. 3133, Thiruvananthapuram, Kerala, 695012.
U24290KL2012GOI030732
030732
12 March 2012
₹285.00 Cr
₹27.49 Cr
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Hll Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amitabh Soni | Director | 25 Apr 2025 | Current |
| Hoveyda Abbas | Nominee Director | 25 Jun 2025 | Current |
| Vijay Nehra | Nominee Director | 01 Oct 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Nominee Director | 02 Apr 2019 | Past |
| Pramod Abcsdd | Nominee Director | 02 Jan 2025 | Past |
| Pramod Abcsdd | Nominee Director | 24 Jan 2022 | Past |
| Pramod Abcsdd | Nominee Director | 10 Apr 2021 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hll Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 92.75% decrease. The company also saw a substantial fall in profitability, with a 101.87% decrease in profit. The company's net worth dipped by a decrease of 1.82%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Hll Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,590,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2017 | Sbicap Trustee Company Limited | ₹309.00 Cr | Open |
| 29 Jun 2016 | Hdfc Bank Limited | ₹50.00 Cr | Open |
| 30 May 2016 | State Bank Of Travancore | ₹100.00 Cr | Open |
Explore comprehensive loan charge details -
Hll Biotech has a workforce of 99 employees as of Oct 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hll Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hll Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vijay Nehra was appointed as a Nominee Director was appointed as a Nominee Director on 01 Oct 2025 & has been associated with this company since 1 month 23 days . was completed.
Progress on Anna Liya Yeldose was appointed as a Company Secretary was appointed as a Company Secretary on 12 Aug 2025 & has been associated with this company since 3 months 14 days . was documented.
The activity Hoveyda Abbas was appointed as a Nominee Director was appointed as a Nominee Director on 25 Jun 2025 & has been associated with this company since 5 months 1 day . was completed.
The activity Amitabh Soni was appointed as a Director was appointed as a Director on 25 Apr 2025 & has been associated with this company since 7 months 1 day . was completed.
The activity Hll Biotech Limited last Annual general meeting of members was held on 11 Dec 2024 as per latest MCA records. was completed.
Progress on Hll Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
The CIN of Hll Biotech Limited is U24290KL2012GOI030732.
Hll Biotech Limited is headquartered at Kumari Geetha S, Neena Mg , Geena Jayaprakash (Joint Owners), Aswathi, Neens, Ward No.42 Door No. 3133, Thiruvananthapuram, Kerala, 695012.
Hll Biotech Limited was incorporated on 12 March 2012.
The current directors of Hll Biotech Limited are
The primary industry of Hll Biotech Limited is Manufacturing.
Hll Biotech Limited is unlisted.
The authorized capital of Hll Biotech Limited is ₹285.00 Cr, and the paid-up capital is ₹27.49 Cr.
The compliance status of Hll Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX